首页> 外国专利> METHOD AND DEVICE FOR PREDICTING AN EFFECTIVE DOSE OR SUSCEPTIBILITY TO 5-HYDROXY-1H-IMIDAZOL-4-CARBOXAMIDE, METHOD FOR DETERMINING THE QUANTITY OF XANTHOSINMINOSPHOSPHATE, ALSO EVERYTHING, ALSO AS A LOST.

METHOD AND DEVICE FOR PREDICTING AN EFFECTIVE DOSE OR SUSCEPTIBILITY TO 5-HYDROXY-1H-IMIDAZOL-4-CARBOXAMIDE, METHOD FOR DETERMINING THE QUANTITY OF XANTHOSINMINOSPHOSPHATE, ALSO EVERYTHING, ALSO AS A LOST.

机译:用于预测5-羟基-1H-咪唑-4-羧酰胺的有效剂量或敏感性的方法和装置,用于测定黄嘌呤次磷酸的量的方法,也包括所有方法。

摘要

An object of the present invention is to provide a method and apparatus for predicting an effective dose of or the sensitivity to 5-hydroxy-1H-imidazole-4-carboxamide, which are capable of performing a determination in a simple operation and a short time, a method for determining amounts of xanthosine monophosphate, and a treatment agent and treatment method for treating myelodysplastic syndrome. According to the present invention, provided are a method for predicting an effective dose of or the sensitivity to 5-hydroxy-1H-imidazole-4-carboxamide, including determining amounts of xanthosine monophosphate in blood and a prediction apparatus, a method for determining amounts of xanthosine monophosphate, including determining xanthosine monophosphate in blood in two different determining conditions by mass spectrometry, and a treatment agent and treatment method for treating myelodysplastic syndrome.
机译:本发明的目的是提供一种预测5-羟基-1H-咪唑-4-羧酰胺的有效剂量或对5-羟基-1H-咪唑-4-羧酰胺的敏感性的方法和设备,其能够在简单的操作和短时间内进行确定。 ,一种确定黄嘌呤单磷酸的量的方法,以及一种用于治疗骨髓增生异常综合症的治疗剂和治疗方法。根据本发明,提供了一种预测5-羟基-1H-咪唑-4-羧酰胺的有效剂量或对5-羟基-1H-咪唑-4-羧酰胺的敏感性的方法,包括确定血液中黄嘌呤单磷酸的量和预测装置,一种确定该量的方法。 ,包括在两种不同的测定条件下通过质谱法测定血液中的黄嘌呤单磷酸,以及治疗骨髓增生异常综合症的治疗剂和治疗方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号